Cited by 1,011Inflammatory mediators and NSAID effectsReceptor Mechanisms and SignalingEicosanoids and Hypertension Pharmacology

The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.

Prostanoid Receptors: Subtypes and Signaling

Breyer, Richard M, Bagdassarian, Carey K, Myers, Scott A, Breyer, Matthew D·2001·Annual Review of Pharmacology and Toxicology

DOI 10.1146/annurev.pharmtox.41.1.661

Open this paper in CoChat — free account

Abstract

Cyclooxygenases metabolize arachidonate to five primary prostanoids: PGE 2, PGF 2α, PGI 2, TxA 2, and PGD 2. These autacrine lipid mediators interact with specific members of a family of distinct G-protein-coupled prostanoid receptors, designated EP, FP, IP, TP, and DP, respectively. Each of these receptors has been cloned, expressed, and characterized. This family of eight prostanoid receptor complementary DNAs encodes seven transmembrane proteins which are typical of G-protein-coupled receptors and these receptors are distinguished by their ligand-binding profiles and the signal transduction pathways activated on ligand binding. Ligand-binding selectivity of these receptors is determined by both the transmembrane sequences and amino acid residues in the putative extracellular-loop regions. The selectivity of interaction between the receptors and G proteins appears to be mediated at least in part by the C-terminal tail region. Each of the EP 1, EP 3, FP, and TP receptors has alternative splice variants described that alter the coding sequence in the C-terminal intracellular tail region. The C-terminal variants modulate signal transduction, phosphorylation, and desensitization of these receptors, as well as altering agonist-independent constitutive activity.

Integrity signals

Registry

Crossref · 10.1146/annurev.pharmtox.41.1.661

Cites

154 of 154 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
Moncada, S., Gryglewski, R. J., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,593
Prostanoid Receptors: Structures, Properties, and Functions
Narumiya, S., Sugimoto, Y., & Ushikubi, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1193 · Cited by 2,417
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.
Coleman, R. A., Smith, W. L., & Narumiya, S. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06784-5 · Cited by 1,747
G Protein-coupled Receptors
Ji, T. H., Grossmann, M., & Ji, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17299 · Cited by 1,281
G-protein-coupled receptor heterodimerization modulates receptor function
Jordan, B. A., & Devi, L. A. (1999) · Nature · doi:10.1038/21441 · Cited by 1,169
The probable arrangement of the helices in G protein‐coupled receptors.
Baldwin, J. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05814.x · Cited by 968
Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary Hypertension
Tuder, R. M., Cool, C. D., Geraci, M. W., Wang, J., Abman, S. H., Wright, L. A., Badesch, D. B., & Voelkel, N. F. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.6.9804054 · Cited by 804
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773
Cloning and expression of cDNA for a human thromboxane A2 receptor
Hirata, M., Hayashi, Y., Ushikubi, F., Yokota, Y., Kageyama, R., Nakanishi, S., & Narumiya, S. (1991) · Nature · doi:10.1038/349617a0 · Cited by 679
Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., et al. (1998) · Nature · doi:10.1038/26233 · Cited by 677

Show all 152 references

Research works printed but not linked: 18

Coleman RA, 1994, Pharmacol. Rev., 46, 205
Leach AR. 1996.Molecular Modelling. Essex, England: Longman Ltd.pp. 25–90
Kolakowski L, 1994, Mol. Pharmacol. Recept. Channels, 2, 1
Morinelli TA, 1989, J. Pharmacol. Exp. Ther., 251, 557
Kinsella BT, 1997, J. Pharmacol. Exp. Ther., 281, 957
Funk CD, 1993, Mol. Pharmacol., 44, 934
Sakamoto K, 1994, J. Biol. Chem., 5, 3381
Fujino H, 2000, Mol. Pharmacol., 57, 353
Coleman RA, Kennedy I, Humphrey PPA, Bunce K, Lumley P. 1990.Prostanoids and their receptors.InComprehensive Medicinal Chemistry, ed. JC Emmet, pp. 643–714. Oxford, UK: Pergamon
Abramovitz M, 1995, Adv. Prostaglandin Thromboxane Leukot. Res., 23, 499
Regan JW, 1994, Mol. Pharmacol., 46, 213
Guan Y, 1996, J. Am. Soc. Nephrol, 7, 1646
Nishigaki N, 1996, Mol. Pharmacol., 50, 1031
Perkins W, 1991, J. Pharmacol. Exp. Ther., 259, 1004
10.1042/0264-6021:3400365 · DOI
Audoly L, 1999, J. Pharmacol. Exp. Ther., 289, 140
Edwards RM, 1985, Am. J. Physiol., 248, F779
Kotani M, 1995, Mol. Pharmacol., 48, 869

Sorted by citations

Items 101–200 of 1,000

Arachidonic acid cascade in endothelial pathobiology
Bogatcheva, N. V., Sergeeva, M. G., Dudek, S. M., & Verin, A. D. (2005) · Microvascular Research · doi:10.1016/j.mvr.2005.01.007 · Cited by 141
The role of prostaglandins E1 and E2, dinoprostone, and misoprostol in cervical ripening and the induction of labor: a mechanistic approach
Bakker, R., Pierce, S., & Myers, D. A. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4418-5 · Cited by 134
RETRACTED ARTICLE: EET signaling in cancer
Panigrahy, D., Greene, E. R., Pozzi, A., Wang, D. W., & Zeldin, D. C. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9315-y · Cited by 134
Retracted
Neuronal oxidative damage from activated innate immunity is EP2 receptor‐dependent
Montine, T. J., Milatović, D., Gupta, R. C., Vályi-Nagy, T., Morrow, J. D., & BREYER, R. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01157.x · Cited by 133
Self-citation
Proinflammatory and Immunoregulatory Roles of Eicosanoids in T Cells
Lone, A. M., & Taskén, K. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00130 · Cited by 131
Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model
Xin, X., Majumder, M., Girish, G. V., Mohindra, V., Maruyama, T., & Lala, P. K. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.90 · Cited by 132
EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival
Kamiyama, M., Pozzi, A., Yang, L., DeBusk, L. M., BREYER, R. M., & Lin, P. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209694 · Cited by 133
Self-citation
Prostaglandin E2-EP4 Receptor Promotes Endothelial Cell Migration via ERK Activation and Angiogenesis in Vivo
Rao, R., Redha, R., Macias‐Perez, I., Yan, S., Hao, C., Zent, R., Breyer, M. D., & Pozzi, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701214200 · Cited by 131
Self-citation
Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia
Liu, D., Wu, L., BREYER, R. M., Mattson, M. P., & Andreasson, K. I. (2005) · Annals of Neurology · doi:10.1002/ana.20461 · Cited by 129
Self-citation
Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells
Han, C. L., Michalopoulos, G. K., & Wu, T. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20560 · Cited by 129
Retracted
Immunosuppressive reprogramming of neutrophils by lung mesenchymal cells promotes breast cancer metastasis
Gong, Z., Li, Q., Shi, J., Li, P., Hua, L., Shultz, L. D., & Ren, G. (2023) · Science Immunology · doi:10.1126/sciimmunol.add5204 · Cited by 130
Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus
Olesen, E. T. B., Rützler, M. R., Moeller, H. B., Prætorius, H. A., & Fenton, R. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104691108 · Cited by 126
PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis
Bilak, M. M., Wu, L., Wang, Q., Haughey, N. J., Conant, K. E., Hillaire, C. S., & Andreasson, K. I. (2004) · Annals of Neurology · doi:10.1002/ana.20179 · Cited by 126
Pharmacology and perspectives in erectile dysfunction in man
Mitidieri, E., Cirino, G., Bianca, R. D. D. V., & Sorrentino, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107493 · Cited by 130
Prostaglandin E2 stimulates angiogenesis by activating the nitric oxide/cGMP pathway in human umbilical vein endothelial cells
Namkoong, S., Lee, S., Kim, C., Kim, Y.-M., Chung, H., Lee, H., Han, J.-A., Ha, K., Kwon, Y., & Kim, Y. (2005) · Experimental & Molecular Medicine · doi:10.1038/emm.2005.72 · Cited by 124
Reversal of Myofibroblast Differentiation by Prostaglandin E2
Garrison, G. W., Huang, S. K., Okunishi, K., Scott, J. P., Penke, L. R. K., Scruggs, A. M., & Peters-Golden, M. L. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0262oc · Cited by 124
Prostaglandin E2 Mediates Cough via the EP3 Receptor: Implications for Future Disease Therapy
Maher, S. A., Birrell, M. A., & Belvisi, M. G. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0388oc · Cited by 126
Matrix Metalloproteinase (MMP)-1 and MMP-3 Induce Macrophage MMP-9: Evidence for the Role of TNF-α and Cyclooxygenase-2
Steenport, M. L., Khan, K. M. F., Du, B., Barnhard, S. E., Dannenberg, A. J., & Falcone, D. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901925 · Cited by 121
The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis
Liang, X., Wang, Q., Shi, J., Lokteva, L. A., BREYER, R. M., Montine, T. J., & Andreasson, K. I. (2008) · Annals of Neurology · doi:10.1002/ana.21437 · Cited by 120
Self-citation
Stimulation of PGE2 receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following β‐amyloid exposure
Echeverrı́a, V., Clerman, A., & Doré, S. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04427.x · Cited by 122
Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation
Kay, L. J., Yeo, W. W., & Peachell, P. T. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706664 · Cited by 118
Prostaglandin E2 Regulates the Nuclear Receptor NR4A2 in Colorectal Cancer
Holla, V. R., Mann, J. R., Shi, Q., & DuBois, R. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507752200 · Cited by 118
Function of COX-2 and Prostaglandins in Neurological Disease
Liang, X., Wu, L., Wang, Q., Hand, T. A., Bilak, M. M., McCullough, L. B., & Andreasson, K. I. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0058-8 · Cited by 118
DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection
Matsuzaki, S., Canis, M. J., Vaurs‐Barrière, C., Pouly, J.-L., Boespflug‐Tanguy, O., Penault-Llorca, F. M., Dechelotte, P., Dastugue, B., Okamura, K., & Mage, G. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah097 · Cited by 118
Prostanoid receptor EP1 and Cox-2 in injured human nerves and a rat model of nerve injury: a time-course study
Durrenberger, P. F., Facer, P., Casula, M. A., Yiangou, Y., Gray, R., Chessell, I. P., Day, N. C., Collins, S. D., Bingham, S., Wilson, A. W., et al. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-1 · Cited by 116
Transactivation of steroidogenic acute regulatory protein in human endometriotic stromal cells is mediated by the prostaglandin EP2 receptor.
Sun, H. S., Hsiao, K.-Y., Hsu, C.-C., Wu, M.-H., & Tsai, S.-J. (2003) · Endocrinology · doi:10.1210/en.2003-0289 · Cited by 114
Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke
Capra, V., Bäck, M., Barbieri, S. S., Camera, M., Tremoli, E., & Rovati, G. E. (2012) · Medicinal Research Reviews · doi:10.1002/med.21251 · Cited by 118
The Neurobiology of Lipid Metabolism in Autism Spectrum Disorders
Tamiji, J., & Crawford, D. A. (2010) · Neurosignals · doi:10.1159/000323189 · Cited by 116
The role of prostaglandins in allergic lung inflammation and asthma
Claar, D. D., Hartert, T. V., & Peebles, R. S. (2014) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2015.992783 · Cited by 113
Macrophage EP4 Deficiency Increases Apoptosis and Suppresses Early Atherosclerosis
Babaev, V. R., Chew, J. D., Ding, L., Davis, S., Breyer, M. D., BREYER, R. M., Oates, J. A., Fazio, S., & Linton, M. F. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.005 · Cited by 114
Self-citation
Fatty Acid Oxidation in the Pathogenesis of Alzheimer's Disease
Montine, T. J., & Morrow, J. D. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62347-4 · Cited by 118
An airway-to-brain sensory pathway mediates influenza-induced sickness
Bin, N.-R., Prescott, S. L., Horio, N., Wang, Y., Chiu, I. M., & Liberles, S. D. (2023) · Nature · doi:10.1038/s41586-023-05796-0 · Cited by 111
Prostanoids as Regulators of Innate and Adaptive Immunity
Hirata, T., & Narumiya, S. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394300-2.00005-3 · Cited by 111
Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity
Shie, F., Montine, K. S., Breyer, R. M., & Montine, T. J. (2005) · Glia · doi:10.1002/glia.20220 · Cited by 110
Self-citation
SO2-Induced Neurotoxicity Is Mediated by Cyclooxygenases-2-Derived Prostaglandin E2 and its Downstream Signaling Pathway in Rat Hippocampal Neurons
Sang, N., Yun, Y., Yao, G., Li, H., Guo, L., & Li, G. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr224 · Cited by 109
A Novel, Non-Prostanoid EP2 Receptor-Selective Prostaglandin E2 Agonist Stimulates Local Bone Formation and Enhances Fracture Healing
Li, M., Ke, H. Z., Qi, H., Healy, D. R., Li, Y., Crawford, D. T., Paralkar, V. M., Owen, T. A., Cameron, K. O., Lefker, B. A., et al. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.11.2033 · Cited by 109
Suppression of Matrix Metalloproteinase-9 by Prostaglandin E2 in Peritoneal Macrophage Is Associated with Severity of Endometriosis
Wu, M., Shoji, Y., Wu, M., Chuang, P., Lin, C.-C., Huang, M., & Tsai, S. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61195-9 · Cited by 108
Endometriosis: disease pathophysiology and the role of prostaglandins
Wu, M., Shoji, Y., Chuang, P., & Tsai, S. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940700021x · Cited by 108
Receptors and Signaling Mechanisms Required for Prostaglandin E2-Mediated Regulation of Mast Cell Degranulation and IL-6 Production
Nguyen, M., Solle, M., Audoly, L., Tilley, S. L., Stock, J. L., McNeish, J. D., Coffman, T. M., Dombrowicz, D., & Koller, B. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4586 · Cited by 108
Prostaglandins and Rheumatoid Arthritis
Fattahi, M. J., & Mirshafiey, A. (2012) · Arthritis · doi:10.1155/2012/239310 · Cited by 110
Rescue of Impaired Fracture Healing in COX-2−/− Mice via Activation of Prostaglandin E2 Receptor Subtype 4
Xie, C. L., Liang, B., Xue, M., Lin, A., Loiselle, A. E., Schwarz, E. M., Guldberg, R. E., O’Keefe, R. J., & Zhang, X. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081099 · Cited by 106
EP4 receptor as a new target for bronchodilator therapy
Buckley, J., Birrell, M. A., Maher, S. A., Nials, A. T., Clarke, D. L., & Belvisi, M. (2011) · Thorax · doi:10.1136/thx.2010.158568 · Cited by 112
Prostaglandin E2Regulates Aromatase Activity and Expression in Human Adipose Stromal Cells via Two Distinct Receptor Subtypes
Richards, J. A., & Brueggemeier, R. W. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021475 · Cited by 104
COX-2 inhibitors: a novel strategy in the management of breast cancer
Regulski, M., Regulska, K., Prukała, W., PIOTROWSKA, H., Stanisz, B. J., & Murias, M. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.12.003 · Cited by 103
Non-COX-2 targets and cancer: Expanding the molecular target repertoire of chemoprevention
Kashfi, K., & Rigas, B. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.004 · Cited by 102
The Prostanoid EP 2 Receptor Agonist Butaprost Increases Uveoscleral Outflow in the Cynomolgus Monkey
NILSSON, S. F. E., Drecoll, E., Lu¨tjen-Drecoll, E., Toris, C. B., Krauss, A. H. ‐., Kharlamb, A. B., Nieves, A. L., Guerra, T., & Woodward, D. F. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1627 · Cited by 103
Prostaglandins in asthma and allergic diseases
Peebles, R. S. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.001 · Cited by 100
Effects of prostaglandins and COX-inhibiting drugs on skeletal muscle adaptations to exercise
Trappe, T. A., & Liu, S. Z. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00061.2013 · Cited by 100
Ovarian epithelial cancer: a role for PGE2-synthesis and signalling in malignant transformation and progression
Rask, K., Zhu, Y., Wang, W., Hedin, L., & Sundfeldt, K. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-62 · Cited by 100
Differential expression of genes in eutopic and ectopic endometrium from patients with ovarian endometriosis
Matsuzaki, S., Canis, M. J., Pouly, J. L., Botchorishvili, R., Déchelotte, P. J., & Mage, G. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.02.093 · Cited by 99
Cyclooxygenase Inhibition in Ischemic Brain Injury
Candelario‐Jalil, E., & Fiebich, B. L. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480216 · Cited by 100
Oxylipin metabolism is controlled by mitochondrial β-oxidation during bacterial inflammation
Misheva, M., Kotzamanis, K., Davies, L. C., Tyrrell, V. J., Rodrigues, P. D. S., Benavides, G. A., Hinz, C., Murphy, R. C., Kennedy, P. D., Taylor, P. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27766-8 · Cited by 104
Alternative splicing of G protein-coupled receptors: physiology and pathophysiology
Markovic, D., & Challiss, R. A. J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0093-4 · Cited by 101
Targeting Prostaglandin E2 Receptors as an Alternative Strategy to Block Cyclooxygenase-2-dependent Extracellular Matrix-induced Matrix Metalloproteinase-9 Expression by Macrophages
Pavlovic, S., Du, B., Sakamoto, K., Khan, K. M. F., Natarajan, C., BREYER, R. M., Dannenberg, A. J., & Falcone, D. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506846200 · Cited by 97
Self-citation
Suppression of Inflammation with Conditional Deletion of the Prostaglandin E 2 EP2 Receptor in Macrophages and Brain Microglia
Johansson, J. U., Pradhan, S., Lokteva, L. A., Woodling, N. S., Ko, N., Brown, H. D., Wang, Q., Loh, C., Cekanaviciute, E., Buckwalter, M., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2203-13.2013 · Cited by 96
Lipid Signaling and Synaptic Plasticity
Sang, N., & Chen, C. (2006) · The Neuroscientist · doi:10.1177/1073858406290794 · Cited by 98
Eicosanoid actions in insect cellular immune functions
STANLEY, D. W., & Miller, J. S. (2006) · Entomologia Experimentalis et Applicata · doi:10.1111/j.1570-7458.2006.00406.x · Cited by 96
Prostaglandin E2 receptors in bone formation
Li, M., Thompson, D. D., & Paralkar, V. M. (2007) · International Orthopaedics · doi:10.1007/s00264-007-0406-x · Cited by 96
Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct
Schafer, J. A. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00068.2002 · Cited by 95
RETRACTED: EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways
Donnini, S., Finetti, F., Solito, R., Terzuoli, E., Sacchetti, A., Morbidelli, L., Patrignani, P., & Ziche, M. (2007) · The FASEB Journal · doi:10.1096/fj.06-7581com · Cited by 95
Retracted
Bisphenol A-induced aromatase activation is mediated by cyclooxygenase-2 up-regulation in rat testicular Leydig cells
Kim, J. Y., Han, E. H., Kim, H. G., Oh, K. N., Kim, S. K., Lee, K. Y., & Jeong, H. G. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.01.011 · Cited by 95
Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent
Kirihara, T., Taniguchi, T., Yamamura, K., Iwamura, R., Yoneda, K., Odani‐Kawabata, N., Shimazaki, A., Matsugi, T., Shams, N. K., & Zhang, J. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22745 · Cited by 94
Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Fuwa, M., Toris, C. B., Fan, S., Taniguchi, T., Ichikawa, M., Odani‐Kawabata, N., Iwamura, R., Yoneda, K., Matsugi, T., Shams, N. K., et al. (2018) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2017.0146 · Cited by 94
Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease
Shi, J., Wang, Q., Johansson, J. U., Liang, X., Woodling, N. S., Priyam, P. G., Loui, T., Merchant, M. J., BREYER, R. M., Montine, T. J., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23677 · Cited by 93
Self-citation
Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer
Krishnan, A. V., Moreno, J., Nonn, L., Malloy, P. J., Swami, S., Peng, L., Peehl, D. M., & Feldman, D. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.12.051 · Cited by 92
Boys, girls and shuttling of SRY and SOX9
Sim, H., Argentaro, A., & Harley, V. R. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.04.002 · Cited by 92
Hemichannels Formed by Connexin 43 Play an Important Role in the Release of Prostaglandin E2 by Osteocytes in Response to Mechanical Strain
Jiang, J. X., & Cherian, P. P. (2003) · Cell Communication & Adhesion · doi:10.1080/cac.10.4-6.259.264 · Cited by 92
Cyclooxygenase 2-derived prostaglandin E 2 regulates the angiogenic switch
Wang, D., & DuBois, R. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307640100 · Cited by 91
Prostanoids as pharmacological targets in COPD and asthma
Rolin, S., Masereel, B., & Dogné, J.-M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.058 · Cited by 91
Eryptosis as a marker of Parkinson's disease
Pretorius, E., Swanepoel, A. C., Buys, A. V., Vermeulen, N., Duim, W., & Kell, D. B. (2014) · Aging · doi:10.18632/aging.100695 · Cited by 95
Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?
Fujino, H., & Regan, J. W. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00162-7 · Cited by 91
Inhaled Prostanoids in the Therapy of Pulmonary Hypertension
Gessler, T., Seeger, W., & Schmehl, T. (2008) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2007.0657 · Cited by 89
Cyclooxygenase-1-derived PGE2 promotes cell motility via the G-protein-coupled EP4 receptor during vertebrate gastrulationPreprint
Cha, Y. I., Kim, S. H., Sepich, D. S., Buchanan, F. G., Solnica‐Krezel, L., & DuBois, R. N. (2006) · Genes & Development · doi:10.1101/gad.1374506 · Cited by 89
PGRL Is a Major CD81-Associated Protein on Lymphocytes and Distinguishes a New Family of Cell Surface Proteins
Clark, K. L., Zeng, Z., Langford, A. L., Bowen, S. M., & Todd, S. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5115 · Cited by 88
Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor
Jiang, J., Ganesh, T., Du, Y., Thepchatri, P., Rojas, A., Lewis, I., Kurtkaya, S., Li, L., Qui, M., Serrano, G. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909310107 · Cited by 88
The Prostaglandin E2Receptor EP4 Is Expressed by Human Platelets and Potently Inhibits Platelet Aggregation and Thrombus Formation
Philipose, S., Kónya, V., Sreckovic, I., Marsche, G., Lippe, I. T., Peskar, B. A., Heinemann, Á., & Schuligoi, R. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.216374 · Cited by 87
Signaling via the prostaglandin E2 receptor EP4 exerts neuronal and vascular protection in a mouse model of cerebral ischemia
Liang, X., Lin, L., Woodling, N. S., Wang, Q., Anacker, C., Pan, T., Merchant, M. J., & Andreasson, K. I. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46279 · Cited by 87
Role of the Prostanoid EP4 Receptor in Iloprost-mediated Vasodilatation in Pulmonary Hypertension
Lai, Y., Pullamsetti, S. S., Dony, E., Weißmann, N., BUTROUS, G. S., Banat, G.-A., Ghofrani, H. A., Seeger, W., Grimminger, F., & SCHERMULY, R. T. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1519oc · Cited by 89
LPS-activated monocytes suppress T-cell immune responses and induce FOXP3+ T cells through a COX-2-PGE2-dependent mechanism
Bryn, T., Yaqub, S., Mahic, M., Henjum, K., Aandahl, E. M., & Taskén, K. (2007) · International Immunology · doi:10.1093/intimm/dxm134 · Cited by 87
Anti-Inflammatory Agents as Cancer Therapeutics
Kashfi, K. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57002-5 · Cited by 87
Prostaglandin F2α inhibits adipocyte differentiation via a Gαq‐Calcium‐Calcineurin‐Dependent signaling pathway
Liu, L., & Clipstone, N. A. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21044 · Cited by 86
Prostaglandin and the Suppression of Phagocyte Innate Immune Responses in Different Organs
de Medeiros, A. I., Peres‐Buzalaf, C., Verdan, F. F., & Serezani, C. H. (2012) · Mediators of Inflammation · doi:10.1155/2012/327568 · Cited by 87
Sympathy for the devil: the role of thromboxane in the regulation of vascular tone and blood pressure
Sellers, M., & Stallone, J. N. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01318.2007 · Cited by 86
PGE2 receptor EP1 renders dopaminergic neurons selectively vulnerable to low‐level oxidative stress and direct PGE2 neurotoxicity
Carrasco, E., Casper, D., & Werner, P. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21425 · Cited by 86
Regulation of AMP-activated protein kinase activity by G-protein coupled receptors: Potential utility in treatment of diabetes and heart disease
Hutchinson, D. S., Summers, R. J., & Bengtsson, T. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.008 · Cited by 88
mPGES-1 as a target for cancer suppression
Nakanishi, M., Gokhale, V. M., Meuillet, E. J., & Rosenberg, D. W. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.006 · Cited by 87
EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-β1 signaling
Lü, A., Zuo, C., He, Y., Chen, G., Piao, L., Zhang, J., Xiao, B., Shen, Y., Tang, J., Kong, D., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77656 · Cited by 86
Self-citation
Cyclooxygenase-2 Inhibits UVB-Induced Apoptosis in Mouse Skin by Activating the Prostaglandin E2 Receptors, EP2 and EP4
Chun, K., Akunda, J. K., & Langenbach, R. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3617 · Cited by 84
Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice
Li, M., Healy, D. R., Li, Y., Simmons, H. A., Crawford, D. T., Ke, H. Z., Pan, L. C., Brown, T. A., & Thompson, D. D. (2005) · Bone · doi:10.1016/j.bone.2005.03.016 · Cited by 84
Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs
Murray, M. T., Hraiki, A., Bebawy, M., Pazderka, C., & Rawling, T. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.008 · Cited by 86
Prostaglandin E2 receptor EP 4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem‐like cell functions
Majumder, M., Xin, X., Liu, L., Girish, G. V., & Lala, P. K. (2014) · Cancer Science · doi:10.1111/cas.12475 · Cited by 83
PGE2 up-regulates EGF-like growth factor biosynthesis in human granulosa cells: new insights into the coordination between PGE2 and LH in ovulation
Ben‐Ami, I., Freimann, S., Armon, L., Dantes, A., Strassburger, D., Friedler, S., Raziel, A., Seger, R., Ron‐El, R., & Amsterdam, A. (2006) · Molecular Human Reproduction · doi:10.1093/molehr/gal068 · Cited by 83
PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation
Kong, D., Shen, Y., Liu, G., Zuo, S., Ji, Y. H., Lü, A., Nakamura, M., Lazarus, M., Stratakis, C. A., BREYER, R. M., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160459 · Cited by 84
Self-citation
Cyclooxygenase-2 and prostaglandin signaling in cholangiocarcinoma
Wu, T. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.04.002 · Cited by 83
Prostaglandin E2-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells
Hawcroft, G., Ko, C. W. S., & Hull, M. A. (2006) · Oncogene · doi:10.1038/sj.onc.1210113 · Cited by 81
Non-steroid anti-inflammatory drugs, prostaglandins, and cancer
Allaj, V., Guo, C., & Nie, D. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-8 · Cited by 80
Prostaglandin E2 Induces Breast Cancer–Related Aromatase Promoters via Activation of p38 and c-Jun NH2-Terminal Kinase in Adipose Fibroblasts
Chen, D., Reierstad, S., Lin, Z., Lü, M., Brooks, C., Li, N., Innes, J. E., & Bulun, S. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4751 · Cited by 80
Developmental regulation of prostacyclin synthase and prostacyclin receptors in the ovine uterus and conceptus during the peri-implantation period
Cammas, L., Reinaud, P., Bordas, N., Dubois, O., Germain, G., & Charpigny, G. (2006) · Reproduction · doi:10.1530/rep.1.00799 · Cited by 80
PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation
Méndez, M., & LaPointe, M. C. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00838.2004 · Cited by 80
Ultraviolet-radiation induced skin inflammation: dissecting the role of bioactive lipids
Nicolaou, A., Pilkington, S. M., & Rhodes, L. E. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.04.005 · Cited by 81

Authors: Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D.
Affiliations: United States Department of Veterans Affairs (US)
ORCID: Breyer, Richard M
Breyer, Matthew D
Venue: Annual Review of Pharmacology and Toxicology
Publisher: Annual Reviews
Published: 2001-04
Volume: 41
Issue: 1
Pages: 661-690
ISSN: 0362-1642 (ISSN-L)
1545-4304
DOI: 10.1146/annurev.pharmtox.41.1.661
OpenAlex: W2129746956
Cited by: 1,011
References: 152
Citations by year: 2026: 7 · 2025: 17 · 2024: 11 · 2023: 22 · 2022: 17 · 2021: 27 · 2020: 37 · 2019: 22 · 2018: 24 · 2017: 32 · 2016: 38 · 2015: 43 · 2014: 50 · 2013: 40 · 2012: 51
FWCI: 5.37
Type: journal article
Language: en
Open access: closed
Locations: The Annual Review of Pharmacology and Toxicology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of General Medical Sciences (GM 15431)
National Institute of Diabetes and Digestive and Kidney Diseases (DK37097, DK46205, R01DK037097, R01DK046205)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords: prostanoid receptors, G protein-coupled receptors, prostaglandins, cyclooxygenase, arachidonic acid metabolism, prostaglandin E2, prostaglandin F2alpha, prostacyclin, thromboxane A2, prostaglandin D2, receptor subtypes, ligand selectivity, splice variants, receptor desensitization, receptor phosphorylation, constitutive receptor activity, signal transduction
MeSH terms: Amino Acid Sequence, Animals, Humans, Molecular Sequence Data, Prostaglandins, Receptors, Prostaglandin, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prostanoid Receptors: Subtypes and Signaling

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks